These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20035977)

  • 21. Lower urinary tract symptoms in women.
    Milsom I
    Curr Opin Urol; 2009 Jul; 19(4):337-41. PubMed ID: 19444118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic impact of schizophrenia.
    Rice DP
    J Clin Psychiatry; 1999; 60 Suppl 1():4-6; discussion 28-30. PubMed ID: 10037163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic consequences of HIV/AIDS in India.
    Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
    Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update: direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(18):388-9. PubMed ID: 15138399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic cost of fecal incontinence.
    Xu X; Menees SB; Zochowski MK; Fenner DE
    Dis Colon Rectum; 2012 May; 55(5):586-98. PubMed ID: 22513438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
    Scitovsky AA; Rice DP
    J Med Pract Manage; 1988; 3(4):234-41. PubMed ID: 10314299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates.
    Nitz NM; Jumadilova Z; Darkow T; Frytak JR; Bavendam T
    Am J Manag Care; 2005 Jul; 11(4 Suppl):S130-9. PubMed ID: 16161386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ectopic pregnancy in the United States: economic consequences and payment source trends.
    Washington AE; Katz P
    Obstet Gynecol; 1993 Feb; 81(2):287-92. PubMed ID: 8423966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urologic diseases in America project: urinary incontinence in males--demographics and economic burden.
    Stothers L; Thom D; Calhoun E
    J Urol; 2005 Apr; 173(4):1302-8. PubMed ID: 15758786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs and resources associated with the treatment of overactive bladder using retrospective medical care claims data.
    Hall JA; Nelson MA; Meyer JW; Williamson T; Wagner S
    Manag Care Interface; 2001 Aug; 14(8):69-75. PubMed ID: 11517841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical visits among adults with symptoms commonly associated with an overactive bladder.
    Kim SH; Boye M; Bhattacharyya SK; Coyne K; Dhawan R
    BJU Int; 2006 Mar; 97(3):551-4. PubMed ID: 16469024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic burden of prostate cancer, California, 1998.
    Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
    Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
    Scitovsky AA; Rice DP
    Public Health Rep; 1987; 102(1):5-17. PubMed ID: 3101123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic burden of overactive bladder in the United States: A systematic literature review.
    Powell LC; Szabo SM; Walker D; Gooch K
    Neurourol Urodyn; 2018 Apr; 37(4):1241-1249. PubMed ID: 29331047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.
    Watanabe JH; Campbell JD; Ravelo A; Chancellor MB; Kowalski J; Sullivan SD
    Urology; 2010 Oct; 76(4):835-40. PubMed ID: 20430422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual productivity costs due to cervical cancer mortality in the United States.
    Insinga RP
    Womens Health Issues; 2006; 16(5):236-42. PubMed ID: 17055376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the annual cost of overactive bladder in Indonesia.
    Setiati S; Santoso BI; Istanti R
    Acta Med Indones; 2006; 38(4):189-92. PubMed ID: 17132881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.